The Macroeconomic Consequences of Renouncing to Universal Access to Antiretroviral Treatment for HIV in Africa: A Micro-Simulation Model

Abstract

AimPrevious economic literature on the cost-effectiveness of antiretroviral treatment (ART) programs has been mainly focused on the microeconomic consequences of alternative use of resources devoted to the fight against the HIV pandemic. We rather aim at forecasting the consequences of alternative scenarios for the macroeconomic performance of countries.MethodsWe used a micro-simulation model based on individuals aged 15–49 selected from nationally representative surveys (DHS for Cameroon, Tanzania and Swaziland) to compare alternative scenarios : 1-freezing of ART programs to current levels of access, 2- universal access (scaling up to 100% coverage by 2015, with two variants defining ART eligibility according to previous or current WHO guidelines). We introduced an “artificial” ageing process by programming methods. Individuals could evolve through different health states: HIV negative, HIV positive (with different stages of the syndrome). Scenarios of ART procurement determine this dynamics. The macroeconomic impact is obtained using sample weights that take into account the resulting age-structure of the population in each scenario and modeling of the consequences on total growth of the economy.ResultsIncreased levels of ART coverage result in decreasing HIV incidence and related mortality. Universal access to ART has a positive impact on workers' productivity; the evaluations performed for Swaziland and Cameroon show that universal access would imply net cost-savings at the scale of the society, when the full macroeconomic consequences are introduced in the calculations. In Tanzania, ART access programs imply a net cost for the economy, but 70% of costs are covered by GDP gains at the 2034 horizon, even in the extended coverage option promoted by WHO guidelines initiating ART at levels of 350 cc/mm3 CD4 cell counts.ConclusionUniversal Access ART scaling-up strategies, which are more costly in the short term, remain the best economic choice in the long term. Renouncing or significantly delaying the achievement of this goal, due to “legitimate” short term budgetary constraints would be a misguided choice.

Public sector services for the prevention of mother-to-child transmission of HIV infection: a micro-costing survey in Namibia and Rwanda

“…[8][9][10] Most industrialized countries are experiencing an economic downturn that is expected to substantially reduce the overseas aid they provide. 26 The present study has several limitations. First, the objective was to cost the components of a defined package of PMTCT interventions.…”

Examining the evidence on the causal effect of HAART on transmission of HIV using the Bradford Hill criteria

“…The economic argument for HIV treatment as prevention requires reinforcement. Economic modeling studies have evolved to reach beyond the individual benefits of HAART to capture first-order and second-order preventive benefits [71,72]; further advances are needed to capture and quantify economic externalities such as orphanhood, child labor and household expenditures as well as macroeconomic effects in endemic countries [74–77]. …”

Towards Universal Voluntary HIV Testing and Counselling: A Systematic Review and Meta-Analysis of Community-Based Approaches

“…Earlier HIV diagnosis supports timely access to ART, which could improve life expectancy and reduce HIV transmission 140–142. Earlier HIV diagnosis linked to ART may also have important socioeconomic effects at the population level, including (1) reducing the number of orphans [143], (2) improving education and employment outcomes [144],[145], and (3) increasing the size of workforces [146],[147].…”